about
Site-specific functionalization of proteins and their applications to therapeutic antibodiesLight-Emitting Agents for Noninvasive Assessment of Kidney Function.Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions.Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics.Effect of dronedarone on renal function in healthy subjects.A Review of Food-Drug Interactions on Oral Drug Absorption.
P2860
Q26830699-49F41D9E-391B-4013-8EE6-69FCB7639C16Q38644629-8ECC5356-89C5-4731-8AD2-21222B82880CQ38679025-84C6745C-3A74-4728-8BF9-C0C3FD2C1C12Q39398250-E3EE891F-D1AF-49D8-9659-598913E0DDFAQ40901259-8601967D-A273-4512-AE7E-3980912A2FD2Q42951307-623AE800-5B6A-4583-99CC-68E07C8001C0Q48117745-C6B23667-545A-4846-A329-0CD47C4D3BEE
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Measurement of renal function during drug development
@ast
Measurement of renal function during drug development
@en
Measurement of renal function during drug development
@nl
type
label
Measurement of renal function during drug development
@ast
Measurement of renal function during drug development
@en
Measurement of renal function during drug development
@nl
prefLabel
Measurement of renal function during drug development
@ast
Measurement of renal function during drug development
@en
Measurement of renal function during drug development
@nl
P2860
P1476
Measurement of renal function during drug development
@en
P2093
D Craig Brater
P2860
P356
10.1046/J.1365-2125.2002.01625.X
P407
P577
2002-07-01T00:00:00Z